Dr. Gartry MD. Clinical Evidence Summary: Resveratrol is a plant polyphenol with real but modest benefits for cardiovascular health, blood sugar regulation, and inflammation, especially in adults with elevated baseline risk. It activates the SIRT1 longevity pathway, but most of what you swallow gets broken down by your liver before reaching your cells. For most people, micronized trans-resveratrol at 150 to 500 mg per day, paired with an absorption enhancer like BioPerine, is the most evidence-backed approach.

Resveratrol has attracted a lot of scientific attention in recent years because of what it appears to do at a cellular level. It is claimed to activate sirtuins, reduce inflammation, and engage some of the same longevity-related pathways that caloric restriction does in animal models. [1]

The clinical picture, however, is more complicated.

Human trials show genuine benefits of resveratrol for cardiovascular health, neurological biomarkers, and blood sugar regulation. [2][3][4] But current results are inconsistent across populations, and a fundamental problem with how the body processes resveratrol limits how much of it actually reaches target tissues.

This article reviews what the research shows about Resveratrol, where it's still developing, and what the evidence-based limitations are. Before we get into the data, you first need a quick understanding of what resveratrol is and where it comes from.

Key Takeaways:

• Resveratrol is a polyphenol and phytoalexin found in grape skins, red wine, peanuts, blueberries, and cranberries. It is produced by plants in response to stress, UV radiation, or fungal attack.
• It acts primarily as an antioxidant and SIRT1 activator to influence pathways linked to metabolism, inflammation, DNA repair, and cellular aging.
• Human clinical trials show the most benefits of Resveratrol in cardiovascular markers, neurological biomarkers (particularly in Alzheimer's disease), and blood sugar regulation. 
• The results of Resveratrol are not uniform across all populations or disease states.
• Resveratrol is rapidly metabolized in the liver, so most of the resveratrol you take is cleared before reaching target tissues. Micronized forms and formulations with absorption enhancers partially address this problem.
• Resveratrol is well tolerated at up to 1g/day; GI side effects (nausea, diarrhea) are the most common issue at doses of 2.5g/day or higher.
• The effects of Resveratrol for cancer, NAFLD, and obesity remain inconclusive in humans.

History and the French Paradox

Resveratrol entered the scientific mainstream in the early 1990s through what epidemiologists called the "French Paradox." 

Despite a diet rich in saturated fat, the French population showed unusually low rates of cardiovascular disease. Researchers traced part of the effect to regular red wine consumption, and resveratrol emerged as the most likely active compound responsible for the protective signal.

The compound moved from cardiovascular research into longevity science in the early 2000s. Harvard researcher David Sinclair and his collaborators published work demonstrating that resveratrol activated sirtuins, a family of NAD+-dependent enzymes linked to lifespan extension in yeast, worms, flies, and mice.

This finding made resveratrol the first widely studied "sirtuin-activating compound" and triggered the modern era of polyphenol-based longevity research.

The clinical translation of those animal findings to human outcomes has been more measured, which is the core tension this article works through.

What Is Resveratrol?

Resveratrol is a polyphenolic stilbenoid compound that plants produce as a defense mechanism against environmental stressors.[5] The stressors could be UV radiation, fungal infection, and physical injury. Since it is synthesized in response to a threat, it's classified as a phytoalexin.

It exists in two isomeric forms: trans-resveratrol and cis-resveratrol.

Trans-resveratrol is the biologically active form and the predominant isomer found in supplements. Cis-resveratrol is not really studied in the literature because it is less stable.

Natural foods that contain resveratrol include: 

• Grape skins and seeds 
• Red wine 
• Peanuts and pistachios 
• Blueberries, cranberries, and mulberries 
• Polygonum cuspidatum root (Japanese knotweed)

Food concentrations, however, are quite low. Red wine at about 1.9 mg/L, for example, would require consuming several liters daily to approach the 150–500 mg doses studied in clinical trials. [6]

Resveratrol became a focus of longevity research because it was found to activate sirtuins, a family of NAD⁺-dependent proteins involved in metabolism, DNA repair, stress response, and cellular aging.

Chemical Structure and Biosynthesis

The full chemical name of resveratrol is 3,5,4′-trihydroxy-trans-stilbene. It belongs to the stilbenoid subclass of polyphenols, characterized by two phenyl rings connected by an ethylene bridge.

Resveratrol exists in two geometric isomers: the (E)-isomer (trans-resveratrol) and the (Z)-isomer (cis-resveratrol). The trans form is biologically active and chemically stable. The cis form is unstable and not meaningfully studied in clinical research. 

Trans-resveratrol can be converted to the cis form on exposure to UV radiation, which is one reason supplement formulations are typically packaged in opaque or amber containers.

In plants, resveratrol is synthesized by the enzyme stilbene synthase using two precursor molecules: malonyl-CoA and 4-coumaroyl-CoA.

The synthesis is triggered by environmental stressors like UV exposure, fungal attack, or physical injury, which is why grape skins (heavily exposed to sun and pathogens) contain higher resveratrol concentrations than other plant parts.

How Does Resveratrol Work in the Body?

Resveratrol activates SIRT1 (Sirtuin 1) protein, an NAD⁺-dependent deacetylase enzyme. SIRT1 regulates many processes, such as glucose and lipid metabolism, mitochondrial activity, inflammation, and DNA damage repair. [7]

Resveratrol also activates AMP-activated protein kinase (AMPK), an enzyme that acts as an energy sensor in cells. AMPK activation improves insulin sensitivity, promotes fatty acid oxidation, and suppresses inflammatory pathways. [8] It is the mechanism through which resveratrol may affect metabolic health.

As a polyphenol, resveratrol reduces oxidative stress directly. It also suppresses inflammatory gene expression. [9]

Pharmacokinetics and the Bioavailability Problem

Resveratrol's oral pharmacokinetics are the single largest constraint on its clinical effectiveness. Gut absorption is high, with roughly 70 percent of an oral dose entering enterocytes. 

However, systemic bioavailability of unmetabolized resveratrol is consistently below 1 percent.

The reason is first-pass metabolism. 

Once absorbed, resveratrol is rapidly conjugated in the intestinal wall and liver into two primary metabolites: resveratrol-3-O-sulfate and resveratrol-3-O-glucuronide. 

These conjugated forms are water-soluble and quickly cleared through the kidneys, leaving only trace amounts of free resveratrol in circulation. Plasma half-life of unmetabolized resveratrol is approximately 90 minutes.

Two formulation strategies partially address this problem: [10]

• Micronization reduces particle size to increase surface area and improve gut absorption
• Piperine co-administration (commonly as BioPerine) inhibits the UDP-glucuronosyltransferase and sulfotransferase enzymes responsible for first-pass conjugation, allowing more unmetabolized resveratrol to reach circulation

Neither strategy eliminates the bioavailability problem entirely. Even with optimized formulations, the amount of free resveratrol reaching target tissues remains a fraction of the administered dose.

A Resveratrol Benefits-by-Condition Scorecard

Health Area	What Research Shows	Strength of Evidence	Best For
Cardiovascular health	Improved endothelial function, reduced LDL oxidation, modest blood pressure improvements	Moderate	Adults with elevated cardiovascular risk
Blood sugar regulation	Reduced HbA1c, improved insulin sensitivity in diabetic populations	Moderate	People with type 2 diabetes or prediabetes
Brain and neuroprotection	Reduced amyloid biomarkers in Alzheimer's trials	Weak to moderate	Patients with diagnosed neurological conditions
Cellular aging and sirtuin activation	SIRT1 activation confirmed; longevity effects shown in animals only	Weak in humans	Theoretical; pair with NAD+ precursor for mechanism logic
Inflammation	Reduced inflammatory markers in some trials	Moderate	Adults with chronic low-grade inflammation
Cancer prevention	Mixed and inconclusive; some signals in lab settings, no firm human evidence	Very weak	Not recommended as a primary intervention
Weight loss/obesity	Inconsistent results across human trials	Very weak	Not a primary use case

Evaluated Clinical Endpoints and Efficacy

Resveratrol has been extensively studied in the literature. Here, we summarize the key benefits of resveratrol as per current data. 

1. Cardiovascular Health

Clinical data suggest that resveratrol may improve cardiovascular health in the following ways: 

• Upregulation of endothelial nitric oxide synthase (eNOS), which increases nitric oxide (NO) production. NO promotes vasodilation, improves endothelial function, and supports flow-mediated dilation [11]
• Reduced LDL oxidation, which decreases atherosclerotic disease [12]
• Reduced the risk of clot formation through mechanisms similar to aspirin [13]
• Reduced blood pressure when combined with other polyphenols 

Although individual trials have found significant cardiovascular benefits, a meta-analysis that pooled the results of all trials examining resveratrol's effect on cardiovascular risk factors did not find consistent benefit across all populations. [14]

The cardiovascular benefits are best seen in people with elevated baseline cardiovascular risk rather than healthy adults with normal lipid profiles. 

2. Inflammation and Immune Modulation

Resveratrol's anti-inflammatory effects operate through several specific molecular pathways. It inhibits Nuclear Factor-kappa B (NF-κB), a transcription factor that drives the expression of inflammatory cytokines and adhesion molecules.

It also downregulates COX-1 and COX-2, the cyclooxygenase enzymes responsible for converting arachidonic acid into prostaglandins involved in pain and inflammation.

Human trials have shown reductions in circulating C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-α) in resveratrol-supplemented groups, particularly in adults with chronic low-grade inflammation. The effect size is modest but reproducible across multiple studies

3. Brain Health and Neuroprotection

Resveratrol crosses the blood-brain barrier, so it can affect the brain directly.

A study found resveratrol reduced amyloid accumulation in the brain, which is directly relevant to Alzheimer's disease pathology. [15]

SIRT1 activation in neurons also suppresses inflammation that causes the progression of Alzheimer's, Parkinson's, and Huntington's disease.

Similar to cardiovascular benefits, the meta-analysis of resveratrol trials did not find significant improvement in memory or cognitive performance. [16]

The documented benefits are seen in disease-specific biomarkers only, and evidence for cognitive benefit in healthy adults without neurological disease is not well established at this time.

4. Blood Sugar Regulation and Metabolic Health

Clinical trials on resveratrol studying patients with type 2 diabetes have shown that it decreased HbA1c (glycated hemoglobin, a measure of three-month average blood sugar control) over 8 weeks. [17] It also reduced insulin resistance and delayed postprandial glucose peaks among study participants.

Mechanistically, resveratrol suppresses Insulin-like Growth Factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) activity, which influences insulin sensitivity and glucose uptake pathways.

This is one of the biochemical routes through which sirtuin activation translates into measurable metabolic improvements in diabetic and prediabetic populations.

A systematic review of such studies found statistically significant improvements in systolic blood pressure, HbA1c, and creatinine in resveratrol-treated groups. [18] The results, however, were not consistent for fasting glucose levels, LDL cholesterol, and overall glycemic control. 

As with cardiovascular and neurological data, the effects appear best in people with existing metabolic dysfunction and not in healthy people.

5. Cellular Aging and Sirtuin Activation

Sirtuins (SIRT1 and SIRT3) are NAD⁺-dependent enzymes. They require adequate NAD⁺ as a co-substrate to function. 

Resveratrol activates SIRT1 and AMPK (AMP-activated protein kinase), and this dual activation directly triggers autophagy, the cellular process by which damaged proteins and organelles are recycled.

Autophagy is one of the central mechanisms linking sirtuin activity to longevity outcomes in animal models. SIRT1 activity, however, is constrained by NAD+ availability, which is why resveratrol's effects depend on adequate NAD+ levels in the cells where it acts.

This is why many resveratrol supplements combine it with NAD⁺ precursors like NMN, since the two work on the same pathway from different points. NMN provides the substrate (NAD⁺), and resveratrol activates the enzyme (SIRT1).

In animal models, resveratrol has been shown to extend lifespan and delay age-related physiological decline. [19]

Human evidence for anti-aging effects is not established clinically yet. Current research has only found biomarker changes (reduced inflammation, improved metabolic markers) rather than longevity outcomes.

Evidence Hierarchy: Mechanism by Mechanism

Biological Target	Mechanism of Action	Highest Level of Evidence	Clinical Consensus
Endothelial nitric oxide synthase (eNOS)	Upregulation of NO production, vasodilation	Human RCTs in adults with elevated cardiovascular risk	Modest but reproducible benefit
SIRT1 (Sirtuin 1)	NAD+-dependent deacetylase activation	In vitro and animal models; limited human biomarker data	Activation confirmed; downstream clinical outcomes unproven
AMPK (AMP-activated protein kinase)	Energy sensor activation, autophagy trigger	In vitro and animal models	Pathway confirmed; human functional outcomes still developing
NF-κB	Inhibition of inflammatory transcription	Human trials in adults with chronic inflammation	Modest reduction in CRP and TNF-α
COX-1 and COX-2	Downregulation of prostaglandin synthesis	In vitro and animal models; limited human data	Mechanism established; clinical analgesic effect not validated
Insulin signaling (via IGF-1, IGFBP-3)	Improved insulin sensitivity in diabetic populations	Human RCTs in type 2 diabetes patients	Statistically significant improvement in HbA1c
Estrogen receptors (ERα, ERβ)	Mixed agonist/antagonist phytoestrogen activity	In vitro and animal models	Real but context-dependent; safety concern in hormone-sensitive conditions
Amyloid plaque pathways	Reduced amyloid biomarkers in Alzheimer's research	Human RCTs in Alzheimer's patients	Biomarker effect documented; cognitive improvement not consistently shown
Cancer cell pathways	Apoptosis induction in vitro	Cell culture and animal models only	No human therapeutic outcomes demonstrated
Lifespan extension	Sirtuin-mediated longevity signaling	Animal models only (yeast, worms, flies, mice)	Not tested in humans

Resveratrol Side Effects and Safety

Resveratrol has been studied at many different dosages in the literature, most of which have been found to be safe. But some adverse effects have also been reported. [20]

Most study populations tolerate up to 1g/day of resveratrol pretty well. At higher doses of 2.5g/day and above, the GI side effects become more common and consist of: 

• Nausea
• Diarrhea
• Vomiting
• Abdominal discomfort 

Resveratrol inhibits cytochrome P450 enzymes, which metabolize a wide range of medications. Inhibiting CYP3A4 in particular can increase plasma concentrations of chemotherapy agents, immunosuppressants, and statins, raising the risk of drug toxicity.

Resveratrol also has an effect on platelet inhibition, which increases your bleeding if you concurrently take blood-thinning medications, including warfarin, aspirin, and NSAIDs.

Resveratrol is classified as a phytoestrogen with mixed agonist and antagonist activity at both estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ). The direction of its activity depends on the tissue, dose, and the individual's hormone status. 

This is also why red wine contains substantially more resveratrol than white wine: red wine fermentation involves prolonged contact between the juice and the grape skins and seeds, where resveratrol is concentrated, while white wine production removes the skins early in the process.

People with estrogen-receptor-positive cancers, endometriosis, or other hormone-sensitive conditions should avoid resveratrol supplementation unless cleared by a physician.

The following individuals should consult a physician before they start Resveratrol supplementation:

• People taking anticoagulants or antiplatelet medications
• Individuals with hormone-sensitive conditions, like gynecological cancers, PCOS, endometriosis, etc
• Pregnant or breastfeeding individuals due to insufficient safety data
• People with liver or kidney disease
• Anyone taking medications metabolized by CYP3A4
  
  

Dr. Dominic Gartry, M.D.: "Resveratrol is generally well-tolerated, but the interactions are real. If a patient is on a blood thinner, a statin, or any medication metabolized through the liver, I always have them check with their physician before starting. The same goes for anyone with a hormone-sensitive cancer history."

Current Limitations and Unproven Claims in Human Clinical Trials

Despite decades of preclinical research, several widely marketed claims about resveratrol are not supported by current human evidence:

• No human trial has shown that resveratrol extends lifespan. Lifespan extension has been demonstrated in yeast, worms, flies, and mice. Equivalent human research has not been conducted and would be extraordinarily difficult to design.
• Reversal of cellular aging has not been clinically demonstrated. Resveratrol activates pathways associated with cellular aging biology, but no human trial has shown measurable reversal of biological age markers.
• Resveratrol does not cure or treat cancer. Some in vitro and animal studies show resveratrol affects cancer cell behavior, but no human trial has demonstrated therapeutic cancer outcomes. Marketing claims to this effect are unsupported.

A central reason for the gap between mechanistic promise and clinical results is the in vitro vs. in vivo problem. In cell culture, researchers can apply resveratrol directly to cells at controlled concentrations, and the compound performs as biology predicts.

Inside the human body, the same compound is rapidly metabolized in the liver before it can reach target tissues at meaningful concentrations. Most "resveratrol does X" findings come from petri dish experiments where this metabolic clearance does not exist.

The implication for buyers is that resveratrol's biology is real, but the gap between cellular potential and clinical outcome remains the field's largest unresolved challenge.

Clinical Indications and Target Populations

It depends on what you're after. 

Resveratrol has the strongest case for adults with elevated cardiovascular risk, blood sugar issues, or chronic inflammation, where multiple human trials show real but modest improvements.

It makes less sense for younger, healthy adults expecting dramatic anti-aging or energy effects, which the human evidence does not support. 

If you decide to take it, prioritize a micronized trans-resveratrol formula with an absorption enhancer like BioPerine, since regular resveratrol powder is poorly absorbed. Pairing it with an NAD+ precursor like NMN may also amplify its sirtuin-activating effect.

Administration, Dosage, and Bioavailability Optimization

Many formulation factors affect how much of the resveratrol you take actually ends up in your circulation, and eventually, in the target tissues.

Before you choose a resveratrol supplement, make sure to check on the label that you get trans-resveratrol form because cis-resveratrol has not been studied in the literature. 

Products that list only "resveratrol" without specifying the isomer may contain a mixed or lower-quality source.

It’s best to take the micronized form of resveratrol. Micronization reduces the size of particles, which increases their surface area for better absorption. Piperine (BioPerine, derived from black pepper) can also be added to the formulation because it also enhances polyphenol absorption. 

The most widely used dose of resveratrol for metabolic and cardiovascular outcomes is  150–500mg/day. Higher doses (1,000mg and above) have been used in Alzheimer's disease research. Currently, there is no established universal optimal dose.

Health Goal	Studied Dose Range	Typical Duration
Cardiovascular markers	150 to 500 mg/day	4 to 12 weeks
Blood sugar/diabetes	250 to 500 mg/day	8 to 12 weeks
Neurological biomarkers (Alzheimer's research)	500 to 1,000 mg/day	12+ months
General longevity/sirtuin support	200 to 500 mg/day	Ongoing
Upper safety limit	1,000 mg/day	Long-term safety has not yet been established beyond 12 months

Frequently Asked Questions (FAQs)

What is the benefit of taking resveratrol? 

The most evidence-supported benefits of resveratrol supported by human trials are on cardiovascular disease markers, neurological biomarkers in Alzheimer's disease, blood sugar regulation in type 2 diabetes, and activation of the SIRT1/sirtuin pathway. 

What foods are high in resveratrol? 

The highest natural concentrations are found in red grape skins and seeds, red wine, peanuts, pistachios, blueberries, cranberries, mulberries, and the root of Polygonum cuspidatum (Japanese knotweed). 

However, the doses studied in clinical trials (150–1,000mg/day) are not equivalent to dietary intake.

What is the best form of resveratrol to take? 

Oral trans-resveratrol, the biologically active form, micronized to improve bioavailability, is the best form of resveratrol to take. Look for products with clearly disclosed doses, no proprietary blends that obscure actual amounts, and third-party testing for purity.

What is resveratrol good for?

Resveratrol has the most evidence behind it for cardiovascular health, blood sugar regulation in type 2 diabetes, and reducing inflammation markers. 

It also activates SIRT1, a longevity-associated enzyme, which is why it's often paired with NAD+ precursors. Effects are strongest in adults with elevated baseline risk and weaker in healthy populations.

What is the downside of resveratrol?

The main downside is bioavailability. Most oral resveratrol gets metabolized by the liver before reaching target tissues, which limits how much actually works. 

At high doses (2.5 g/day and above), it can cause nausea, diarrhea, and abdominal discomfort. It also interacts with blood thinners, statins, and estrogen-sensitive conditions.

Does resveratrol lower estrogen?

Resveratrol can act as both a weak estrogen and an estrogen blocker depending on the tissue, dose, and individual hormone levels. For most healthy adults, the effect is mild. 

People with hormone-sensitive conditions like estrogen-receptor-positive cancers, endometriosis, or PCOS should talk to a doctor before supplementing.

Is resveratrol worth taking?

For adults with elevated cardiovascular risk, blood sugar issues, or chronic inflammation, resveratrol has moderate evidence behind it.

For healthy younger adults expecting dramatic anti-aging or energy results, the human evidence is weak. Pair it with an NAD+ precursor and use a micronized form for the best chance of meaningful effect.

Is resveratrol good for skin?

Topical resveratrol applied to the skin has shown modest benefits for tone and texture in cosmetic studies. Oral resveratrol has not been shown in human trials to visibly improve skin, reduce wrinkles, or change skin aging.

If skin is your main goal, topical products have better evidence than capsules.

For clinical applications requiring optimized oral bioavailability, formulations like Omre's NMN + Resveratrol utilize 500 mg of micronized trans-resveratrol co-administered with piperine (as BioPerine) to inhibit first-pass glucuronidation, alongside 500 mg of NMN to sustain the NAD+ substrate required for sirtuin activation. The formulation is manufactured in a GMP-certified, FDA-registered US facility with batch-level third-party Certificates of Analysis.

References

[1] Rogina B, Tissenbaum HA. SIRT1, resveratrol and aging. Front Genet. 2024;15:1393181. doi:10.3389/fgene.2024.1393181. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11112063/

[2] Bonnefont-Rousselot D. Resveratrol and Cardiovascular Diseases. Nutrients. 2016;8(5):250. doi:10.3390/nu8050250. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4882663/

[3] Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi-Rad M, et al. Resveratrol: A double-edged sword in health benefits. Food Sci Nutr. 2018;6(8):2473-2490. doi:10.1002/fsn3.855. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6261232/

[4] Zhu X, Wu C, Qiu S, Yuan X, Li L. Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis. Nutr Metab (Lond). 2017;14:60. doi:10.1186/s12986-017-0217-z. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC5610395/

[5] Weiskirchen S, Weiskirchen R. Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy? Adv Nutr. 2016;7(4):706-718. doi:10.3945/an.115.011627. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4942868/

[6] Lan F, Weikel KA, Cacicedo JM, Ido Y. Resveratrol-Induced AMP-Activated Protein Kinase Activation Is Cell-Type Dependent: Lessons from Basic Research for Clinical Application. Nutrients. 2017;9(7):751. doi:10.3390/nu9070751. Available from: https://pubmed.ncbi.nlm.nih.gov/28708087/

[7] Garcia-Garcia LP, Cisneros-Rodriguez B, Ahuactzi-Macia S, Garcia-Carmona M, Bobadilla-Lugo RA, Sanchez-Salgado JC, et al. Oral administration of resveratrol reduces oxidative stress generated in the hippocampus of Wistar rats in response to consumption of ethanol. Front Behav Neurosci. 2024;17:1304006. doi:10.3389/fnbeh.2023.1304006. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10810024/

[8] Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi-Rad M, et al. Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol. Int J Mol Sci. 2019;20(6):1381. doi:10.3390/ijms20061381. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6471659/

[9] Akbari M, Tamtaji OR, Lankarani KB, Tabrizi R, Dadgostar E, Kolahdooz F, et al. The Effects of Resveratrol Supplementation on Endothelial Function and Blood Pressures Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. High Blood Press Cardiovasc Prev. 2019;26(4):305-319. doi:10.1007/s40292-019-00324-6. Available from: https://link.springer.com/article/10.1007/s40292-019-00324-6

[10] Cao X, Liao W, Xia H, Wang S, Sun G. The Effect of Resveratrol on Blood Lipid Profile: A Dose-Response Meta-Analysis of Randomized Controlled Trials. Nutrients. 2022;14(18):3755. doi:10.3390/nu14183755. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9506025/

[11] Tomac I, Šeruga M, Labuda J. Resveratrol in Prevention and Control of Cardiovascular Disorders and Cardiovascular Complications Related to COVID-19 Disease: Mode of Action and Approaches Explored to Increase Its Bioavailability. Molecules. 2021;26(10):2834. doi:10.3390/molecules26102834. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8151233/

[12] Liu Y, Ma W, Zhang P, He S, Huang D. Effect of resveratrol on blood pressure: A meta-analysis of randomized controlled trials. Clin Nutr. 2015;34(1):27-34. doi:10.1016/j.clnu.2014.03.009. Available from: https://www.sciencedirect.com/science/article/pii/S0261561414000843

[13] Puranik N, Kumari M, Tiwari S, Dhakal T, Song M. Resveratrol as a Therapeutic Agent in Alzheimer's Disease: Evidence from Clinical Studies. Nutrients. 2025;17(15):2557. doi:10.3390/nu17152557. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12348645/

[14] Dvorakova M, Landa P. Anti-inflammatory activity of natural stilbenoids: A review. Pharmacol Res. 2017;124:126-145. doi:10.1016/j.phrs.2017.08.002. Available from: https://www.sciencedirect.com/science/article/abs/pii/S1043661817308125

[15] Hausenblas HA, Schoulda JA, Smoliga JM. Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus: a systematic review and meta-analysis. Nutr Res. 2017. doi:10.1016/j.nutres.2017. Available from: https://www.sciencedirect.com/science/article/pii/S0271531717308692

[16] Nyambuya TM, Nkambule BB, Mazibuko-Mbeje SE, Mxinwa V, Mokgalaboni K, Orlando P, et al. A Meta-Analysis of the Impact of Resveratrol Supplementation on Markers of Renal Function and Blood Pressure in Type 2 Diabetic Patients on Hypoglycemic Therapy. Molecules. 2020;25(23):5645. doi:10.3390/molecules25235645. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7730696/

[17] Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending lifespan. Cell Metab. 2008;8(2):157-168. doi:10.1016/j.cmet.2008.06.011. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC2538685/

[18] Shaito A, Posadino AM, Younes N, Hasan H, Halabi S, Alhababi D, et al. Potential Adverse Effects of Resveratrol: A Literature Review. Int J Mol Sci. 2020;21(6):2084. doi:10.3390/ijms21062084. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7139620/